HGF and myocardial infarction: Investigations of TIMP-1 have shown attenuated maladaptive cardiac remodeling at the site of myocardial infarction, inhibition of cardiomyocyte apoptosis, and enhanced pro-vasculogenic factor release from cardiac fibroblasts, including VEGF, FGF, and HGF [29].